Article Review: Overview of Covid-19
DOI:
https://doi.org/10.31033/ijrasb.9.2.19Keywords:
Cryptosporidium Parvum, Chronic diarrhea, Entamoeba histolytica, Giardia lambilia, Modified Zeihl Neelsen staining, ELISAAbstract
The coronary virus family involves human pathogens of great importance, so that at the end of December 2019, the new CORONA virus was identified as the origin of a set of cases of pneumonia of unidentified causes in Wuhan, a city in China’s Hubei Province. The recent coronavirus quickly turned into widespread and challenging to deal with, leading to its transmission throughout China, followed by a rising number of cases in many communities around the world. COVID-19 is spread through large drops generated during coughing and sneezing by cases with symptoms of the disease, as well as individuals who do not show manifestations before their symptoms begin. Many research has reported that the incubation period for Coronara virus infection 2 (SARS-Cove-2) is 14 days after exposure to the virus four to five days. People of all ages may be infected with SARS-HIV-2, although people are common in middle-aged and older age groups. The clinical characteristics that accompany the patient include fever, dry cough, fatigue, sore throat, runny nose, conjunctivitis headaches, muscle pain, shortness of breath, nausea, vomiting and diarrhea. So, however, there are no particular clinical features that accurately differentiate COVID-19 from other viral infections in the upper/lower airway. In a subset of cases, however, by the end of the first week of infection, COVID-19 may progress into pneumonia and pulmonary failure followed by death. The aim here is to discuss COVID-19 in term of virology and epidemiology to continuing clinical demonstrations, diagnosis and complications, and to complete possible management options and conclusion.
Downloads
References
American Academy of Pediatrics. Red book: 2018 report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018
Centers for Disease Control and Prevention. How flu spreads [Internet]. Atlanta, GA: Centres for Disease Control and Prevention; 2018 [cited 2020 Sep 14]. Available from: https://www.cdc.gov/flu/about/disease/spread.htm
Ontario Agency for Health Protection and Promotion (Public Health Ontario). COVID-19 – What we know so far about…asymptomatic infection and asymptomatic transmission [Internet]. Toronto, ON: Queen’s Printer for Ontario; 2020 [cited 2020 Sep 16]. Available from: https://www.publichealthontario.ca/-/media/documents/ncov/what-we-know-jan-30- 2020.pdf?la=en
Ontario Agency for Health Protection and Promotion (Public Health Ontario). COVID-19: aerosol generation from coughs and sneezes [Internet]. Toronto, ON: Queen’s Printer for Ontario; 2020 [cited 2020 Sep 16]. Available from: https://www.publichealthontario.ca/- /media/documents/ncov/ipac/report-covid-19-aerosol-generation-coughs-sneezes.pdf?la=en
Ontario Agency for Health Protection and Promotion (Public Health Ontario). COVID-19 routes of transmission – what we know so far [Internet]. Toronto, ON: Queen’s Printer for Ontario; 2020 [cited 2020 Sep 16]. Available from: https://www.publichealthontario.ca/- /media/documents/ncov/wwksf-routes-transmission-mar-06-2020.pdf?la=en
Ontario Agency for Health Protection and Promotion (Public Health Ontario), Provincial Infectious Diseases Advisory Committee. Routine practices and additional precautions in all health care settings. 3rd ed. Toronto, ON: Queen’s Printer for Ontario; 2012. Available from: https://www.publichealthontario.ca/-/media/documents/B/2012/bp-rpap-healthcaresettings.pdf?la=en
Ontario Agency for Health Protection and Promotion (Public Health Ontario). IPAC recommendations for use of personal protective equipment for care of individuals with suspect or confirmed COVID-19 [Internet]. Toronto, ON: Queen’s Printer for Ontario; 2020 [cited 2020 Sep 16]. Available from: https://www.publichealthontario.ca/- /media/documents/ncov/updated-ipac-measures-covid-19.pdf?la=en
Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infect Dis. 2014;14:480. Available from: https://doi.org/10.1186/1471-2334-14-480
Alimohamadi Y, Taghdir M, Sepandi M. Estimate of the basic reproduction number for COVID19: a systematic review and meta-analysis. J Prev Med Public Health. 2020;53(3):151-7. Available from: https://doi.org/10.3961/jpmph.20.076
Reis J, Shaman J. Retrospective parameter estimation and forecast of respiratory syncytial virus in the United States. PLoS Comput Biol. 2016;12(10):e1005133. Available from: https://doi.org/10.1371/journal.pcbi.1005133
Johns Hopkins Center for Health Security. COVID-19: updates on the emerging novel coronavirus pandemic from the Johns Hopkins Center for Health Security [Internet]. Baltimore, MD: Johns Hopkins University: 2020 [modified 2020 Sep 04; cited 2020 Sep 10]. Available from: https://myemail.constantcontact.com/COVID-19-Updates---September-4-- 2020.html?soid=1107826135286&aid=fr77RrwKNDs
Heymann DL, American Public Health Association. Control of communicable diseases manual: an official report of the American Public Health Association. 20th ed. Washington, DC: APHA Press; 2015
Young K, Gemmill I, Harrison R. Summary of the NACI Seasonal Influenza Vaccine Statement for 2020-2021. Can Commun Dis Rep. 2020;46(5):132-7. Available from: https://doi.org/10.14745/ccdr.v46i05a06
Aoki FY, Allen UD, Mubareka S, Papenburg J, Stiver HG, Evans GA. Use of antiviral drugs for seasonal influenza: foundation document for practitioners – update 2019. JAMMI. 2019;4(2):60- 82. Available from: https://doi.org/10.3138/jammi.2019.02.08
World Health Organization. Q&A: dexamethasone and COVID-19 [Internet]. Geneva: World Health Organization; 2020 [cited 2020 Sep 14]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answershub/q-a-detail/q-a-dexamethasone-and-covid-19
Ai, T.; Yang, Z.; Hou, H.; Zhan, C.; Chen, C.; Lv, W.; Tao, Q.; Sun, Z.; Xia, L. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology 2020.
Health Canada. Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms [Internet]. Ottawa, ON: Government of Canada; 2020 [modified 2020 Aug 28; cited 2020 Sep 14]. Available from: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/73621a-
World Health Organization. Infection prevention and control during health care when COVID-19 is suspected https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)- infection-is-suspected-20200125
Li, Y.; Xia, L. Coronavirus disease 2019 (COVID-19): Role of chest CT in diagnosis and management. AJR Am. J. Roentgenol. 2020, 1–7. [CrossRef]
Bai, H.X.; Hsieh, B.; Xiong, Z.; Halsey, K.; Choi, J.W.; Tran, T.M.L.; Pan, I.; Shi, L.B.; Wang, D.C.; Mei, J.; et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology 2020.
Katharina ,B.(2020). Coronavirus Returns to Europe., Statista
Jhons Hobkins .corona virus resource center .2020
World Health Organization . Coronavirus disease 2019 (COVID-19)
Ontario. Ministry of Health. COVID-19 reference document for symptoms [Internet]. Version 7.0. Toronto, ON: Queen’s Printer for Ontario; 2020 [modified 2020 Sep 21; cited 2020 Sep 28]. Available from: http://www.health.gov.on.ca/en/pro/programs/publichealth/coronavirus/docs/2019_reference _doc_symptoms.pdf
Lippi, G.; Simundic, A.M.; Plebani, M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin. Chem. Lab. Med. 2020.
Lagier, J.C.; Colson, P.; Tissot Dupont, H.; Salomon, J.; Doudier, B.; Aubry, C.; Gouriet, F.; Baron, S.; Dudouet, P.; Flores, R.; et al. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med. Infect. Dis. 2020.
Won, J.; Lee, S.; Park, M.; Kim, T.Y.; Park, M.G.; Choi, B.Y.; Kim, D.; Chang, H.; Kim, V.N.; Lee, C.J.; et al. Development of a laboratory-safe and low-cost detection protocol for SARS-CoV-2 of the coronavirus disease 2019 (COVID-19). Exp. Neurobiol. 2020.
Loeffelholz, M.J.; Tang, Y.W. Laboratory diagnosis of emerging human coronavirus infections–The state of the art. Emerg. Microbes Infect. 2020, 9, 747–756.
World Health Organization Coronavirus Disease (COVID-19) Technical Guidance: Laboratory Testing for 2019-nCoV in Humans. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus2019/technical-guidance/laboratory-guidance (accessed on 31 March 2020).
Ling, Y.; Xu, S.B.; Lin, Y.X.; Tian, D.; Zhu, Z.Q.; Dai, F.H.; Wu, F.; Song, Z.G.; Huang, W.; Chen, J.; et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin. Med. J. 2020. [CrossRef] Int. J. Environ. Res. Public Health 2020, 17, 2690 10 of 11
Lim, J.; Jeon, S.; Shin, H.Y.; Kim, M.J.; Seong, Y.M.; Lee, W.J.; Choe, K.W.; Kang, Y.M.; Lee, B.; Park, S.J.; et al. Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: The application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J. Korean Med. Sci. 2020, 35
Centers for Disease Control and Prevention. Similarities and differences between flu and COVID19 [Internet]. Atlanta, GA: Centres for Disease Control and Prevention; 2020 [cited 2020 Sep 14]. Available from: https://www.cdc.gov/flu/symptoms/flu-vs-covid19.htm
Government of Canada. COVID-19 signs, symptoms and severity of disease: a clinician guide [Internet]. Ottawa, ON: Government of Canada; 2020 [modified 2020 Aug 14; cited 2020 Sep 14]. Available from: https://www.canada.ca/en/public-health/services/diseases/2019-novelcoronavirus-infection/guidance-documents/signs-symptoms-severity.html
World Health Organization. Q&A: influenza and COVID-19 – similarities and differences [Internet]. Geneva: World Health Organization; 2020 [cited 2020 Sep 14]. Available from: https://www.who.int/westernpacific/news/q-a-detail/q-a-similarities-and-differences-covid-19- and-influenza
Dearlove B, Lewitus E, Bai H, Li Y, Reeves DB, Joyce MG, et al. A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants. Proc Natl Acad Sci U S A. 2020;117(38):23652-62. Available from: https://doi.org/10.1073/pnas.2008281117
Ontario. Ministry of Health and Long-Term Care. Control of respiratory infection outbreaks in long-term care homes, 2018. Toronto, ON: Queen’s Printer for Ontario; 2018. Available from: http://health.gov.on.ca/en/pro/programs/publichealth/oph_standards/docs/reference/RESP_In fectn_ctrl_guide_LTC_2018_en.pdf
Centers for Disease Control and Prevention. Clinical questions about COVID-19: questions and answers [Internet]. Atlanta, GA: Centres for Disease Control and Prevention; 2020 [modified 2020 Aug 04; cited 2020 Sep 14]. Available from: https://www.cdc.gov/coronavirus/2019- ncov/hcp/faq.htm
Ai, T. et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 Cases. Radiology https://doi.org/10.1148/radiol.2020200642 (2020).
Artifcial intelligence vs COVID-19: limitations, constraints and pitfalls., AI & SOCIETY
Fang, Y. et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. https://doi.org/10.1148/radiol.2020200432 (2020).
Hayder,T.(2019). Viruses: General Properties.Al-Toosi University College Department of Medical Laboratory Technique 3rd Stage.
He, X. et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. https://doi.org/10.1038/s41591-020-0869-5 (2020).
Hoehl, S. et al. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. N. Engl. J. Med . https://doi.org/10.1056/NEJMc2001899 (2020).
Inui, S. et al. Chest CT findings in cases from the cruise ship “Diamond Princess” with coronavirus disease 2019 (COVID-19). Radiol. Cardiothorac. Imaging. 2, p.e200110 https://doi.org/10.1148/ryct.2020200110 (2020).
Jin, S. et al. AI-assisted CT imaging analysis for COVID-19 screening: building and deploying a medical AI system in four weeks. medRxiv https://www.medrxiv.org/content/10.1101/2020.1103.1119.20039354v20039351 (2020).
Lai, C. C. et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J. Microbiol. Immunol. Infect. https://doi.org/10.1016/j.jmii.2020.02.012 (2020).
Li, Y. & Xia, L. Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management. Am. J. Roentgenol. 1–7. https://doi.org/10.2214/AJR.20.22954 (2020).
Naude,W.(2010).New.www.thelancet.com/digital-health Vol. 2 April 2020 e166-e167
Ranney, M. L., Griffeth, V. & Jha, A. K. Critical supply shortages—the need for ventilators and personal protective equipment during the Covid-19 pandemic. N. Engl. J. Med. https://doi.org/10.1056/NEJMp2006141 (2020).
Rubin, G. D. et al. The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner society. Chest https://doi.org/10.1148/radiol.2020201365 (2020).
Sohrabi, C. et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J. Surg. 76, 71–76 (2020).
Sverzellati, N. et al. Integrated radiologic algorithm for COVID-19 pandemic. J. Thorac. Imaging. https://doi.org/10.1097/RTI.0000000000000516 (2020).
Unhale,S.S.; Ansar, Q.B.; Sanap,S.; Thakhre,S.; Wadatkar,S.; Bairagi,R.; Sagrule,S. and Biyani K.R. (2020) . A REVIEW ON CORONA VIRUS (COVID-19). World Journal of Pharmaceutical and Life Sciences WJPLS., Vol. 6, Issue 4, 109-111.
Wang, S. et al. A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19). medRxiv. Preprint at https://www.medrxiv.org/content/10.1101/2020.02.14.20023028v5 (2020).
Xie, X. et al. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. https://doi.org/10.1148/radiol.2020200343 (2020).
Yang, Y. et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. medRxiv. Preprint at https://www.medrxiv.org/content/10.1101/2020.02.11.20021493v2 (2020).
Yu, M. et al. Thin-section chest CT imaging of coronavirus disease 2019 pneumonia: comparison between patients with mild and severe disease. Radiol. Cardiothorac. Imaging 2 https://doi.org/10.1148/ryct.2020200126 (2020).
Zhao, W., Zhong, Z., Xie, X., Yu, Q. & Liu, J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. Am. J. Roentgenol. 1–6. https://doi.org/10.2214/AJR.20.22976 (2020).
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
editor@ijrasb.com 